Stockholders' Equity |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Stockholders Equity [Abstract] | |
| Stockholders' Equity | (9) Stockholders’ Equity On July 1, 2022, the
Company filed a shelf registration statement to sell up to $150 million in
common and preferred stock, debt securities and warrants. Additionally, the
Company entered into an Equity Distribution Agreement (the “Equity Distribution
Agreement”) with Piper Sandler & Co. (“Piper Sandler” or the “Sales Agent”)
and filed a related prospectus establishing an “at-the-market” facility,
pursuant to which the Company may offer and sell shares of common stock from
time to time through the Sales Agent. In October 2023, the Sales Agent was authorized to sell
shares for aggregate proceeds up to $16.7 million at current market prices
until all shares are sold. During the quarter ended
March 31, 2025, approximately 3.7 million shares of common stock have been sold
for aggregate proceeds of approximately $5.4 million, and as of March 31, 2025,
approximately $1.6 million remains available for sale pursuant to the
prospectus. As of March 31, 2025, the amount the Company is authorized to sell is
subject to baby-shelf limitations. As
of March 31, 2025, the Company had 27,087,886 shares of common stock
outstanding, and no dividends have been declared or paid.
|